Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Atlas Venture Fund X, LP. Officer active across 1 company, notably Kymera Therapeutics, Inc.. In total, 8 reports have been recorded. Activity tracked since 17 June 2026. The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
66,177 shares@ US$108.120.073% mcap13.0% of flowCommon StockSEC144:0001628280-26-046097
410,427 shares@ US$116.460.49% mcap87.0% of flowCommon StockSEC144:0001628280-26-045808
480,992 shares@ US$99.87Common StockSEC144:0001628280-26-045609
118,178 shares@ US$98.25Common StockSEC144:0001628280-26-045290
1,235 shares@ US$99.45Common StockSEC144:0001628280-26-044984
243,976 shares@ US$90.43Common StockSEC144:0001628280-26-044731
100,928 shares@ US$89.90Common StockSEC144:0001628280-26-044425
92,169 shares@ US$87.44Common StockSEC144:0001628280-26-044011